POLYPRAGMASIA AND DRUG LOAD DEPENDING ON THE STATE OF KIDNEY FUNCTION OF PATIENTS SUFFERING FROM DIABETES MELLITUS

Author:

Batishcheva Galina Alexandrovna,Goncharova Natalia Yurievna,Cherenkova Olga VladimirovnaORCID,Eliseeva Daria Mikhailovna,Kotlyarova Daria Kirillovna

Abstract

Type 2 diabetes mellitus is often combined with other diseases, which increases the likelihood of polypragmasia. For the correct dosage regimen of drugs, it is necessary to take into account the state of kidney function, the change of which may be associated with diabetic nephropathy. The aim of the study was to determine the structure of comorbid pathology in patients with type 2 diabetes mellitus and to evaluate the dosage regimen of hypoglycemic drugs taking into account the state of the kidneys. A retrospective analysis of 100 medical records of patients hospitalized in the endocrinology department of the Russian Railways Medicine Clinical Hospital from January to April 2022 was carried out. Patients were divided into groups depending on the presence or absence of CRD (chronic renal disease). Hypoglycemic therapy was evaluated by calculating the drug burden index (DBI) in DDD units for 10 days of pharmacotherapy with oral hypoglycemic and insulin drugs. It was found that arterial hypertension (85%), dyslipidemia (67%), obesity (62%) prevailed in the structure of comorbid pathology in patients with diabetes mellitus. Polypragmasia was detected in 87% of patients. Decrease of glomerular filtration rate (GFR40 ml/min) was found in 61% of patients. The study showed that while maintaining kidney function (GFR 60 ml/min) in the selected cohort of patients, the average DBI value for oral drugs reached 34 DDD units for 10 days of pharmacotherapy, for insulin preparations - 13 DDD units for 10 days of pharmacotherapy. In patients with reduced GFR40 ml/min, the average DBI value for oral medications was significantly lower, reaching 8.6 DDD units for 10 days of pharmacotherapy, for insulin preparations 7.6 DDD units for 10 days of pharmacotherapy, indicating a decrease in the number of drug prescriptions.

Publisher

VSMU N.N. Burdenko

Reference10 articles.

1. Бураев, А. Б. Сахарный диабет II типа: основные аспекты / А. Б. Бураев, Д. В. Кулумбегова, Ф. Р. Бицуева. — Текст : непосредственный // Молодой ученый. — 2022. — № 36 (431). — С. 10-12.

2. Дедов И.И., Шестакова М.В., Майоров А.Ю. «Алгоритмы специализированной медицинской помощи больным СД»// Министерство здравоохранения Российской Федерации, ОО «Российская ассоциация эндокринологов», ФГБУ «Национальный медицинский исследовательский центр эндокринологии».- Москва, 2021.

3. IDF Diabetes Atlas 10th edition/ Brussels: International Diabetes Federation; 2022: [Электронный ресурс].URL: https://diabetesatlas.org/. (Дата обращения: 15.01.2023)

4. «Федеральный Регистр сахарного диабета» РФ: [Электронный ресурс]. URL: https://sd.diaregistry.ru/content/o-proekte.html#content. (Дата обращения: 31.01.2023)

5. Волошинова Е., Лобанова О., Куницына М., Григорьева Е., Цатурова К. «Коморбидность у больных сахарным диабетом типа 2» // Журнал для практических врачей всех специальностей «Врач», том 29, номер 1, 2018. С. 38-39.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3